IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors (2017)
Attributed to:
USE OF LOW-DOSE IL-2 TO EXPAND ENDOGENOUS REGULATORY T CELLS AND ACHIEVE TRANSPLANTATION TOLERANCE
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1620835114
PubMed Identifier: 28584086
Publication URI: http://europepmc.org/abstract/MED/28584086
Type: Journal Article/Review
Parent Publication: Proceedings of the National Academy of Sciences
Issue: 27
ISSN: 0027-8424